Decahydroquinolines and central analgesic method of use thereof
    2.
    发明授权
    Decahydroquinolines and central analgesic method of use thereof 失效
    十氢喹啉和中枢镇痛药的使用方法

    公开(公告)号:US4877796A

    公开(公告)日:1989-10-31

    申请号:US084456

    申请日:1987-08-12

    CPC分类号: C07D215/40

    摘要: A compound selected from the group consisting of all enantiomeric and diastereoisomeric forms of a decahydroquinoline of the formula ##STR1## wherein R.sub.1 is alkyl of 1 to 5 carbon atoms, R.sub.2 is selected from the group consisting of hydrogen and akyl of 1 to 5 carbon atoms, A is selected from the group consisting of --(CH.sub.2).sub.n --, --CH.sub.2 O-- and alkylene substituted with alkyl having a total of 2 to 8 carbon atoms, n is an integer from 0 to 5, Z is selected from the group consisting of optionally substituted phenyl, optionally substituted naphthyl, optionally substituted indenyl, optionally substituted heteromonocycle of 5 to 6 members and optionally substituted heterobicycle with the proviso that when Z is o-alkoxy-phenyl, A is not --(CH.sub.2).sub.n -- in which n is O, and their non-toxic, pharmaceutically acceptable acid addition salts and their quaternary ammonium salts and intermediates having analgesic, diuretic, hypotensive, anti-arrithmic and anti-cerebral-ischaemic properties.

    摘要翻译: 选自下式的化合物:其中R 1为1至5个碳原子的烷基,R 2选自氢和1至5个碳原子的烷基的所有对映异构体和非对映异构体形式的十氢喹啉的化合物 原子,A选自 - (CH 2)n - , - CH 2 O-和被具有总共2至8个碳原子的烷基取代的亚烷基,n是0至5的整数,Z选自 由任选取代的苯基,任选取代的萘基,任选取代的茚基,任选取代的5至6个成员的异单环和任选取代的杂双环,条件是当Z是邻 - 烷氧基 - 苯基时,A不是 - (CH2)n-,其中 n是O,它们的无毒的药学上可接受的酸加成盐及其季铵盐和具有止痛,利尿,降压,抗对数和抗脑缺血性质的中间体。

    Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions
and use
    3.
    发明授权
    Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions and use 失效
    α-巯基甲基苯丙酰胺,药物组合物和用途

    公开(公告)号:US4839358A

    公开(公告)日:1989-06-13

    申请号:US159265

    申请日:1988-02-23

    CPC分类号: C07D295/32

    摘要: Novel .alpha.-mercaptomethyl-benzene propanamides of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen and ##STR2## R.sub.1 ' is selected from the group consisting of alkyl of 1 to 5 carbon atoms and aryl optionally substituted with at least one member of the group consisting of --OH, --NO.sub.2, halogen and alkyl and alkoxy of 1 to 5 carbon atoms, X and X' are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 5 carbon atoms, --OH, halogen and --CF.sub.3, R.sub.2 is selected from the group consisting of pyrrolidinyl, morpholinyl, piperidinyl, piperazinyl, tetrahydrothiazinyl and hexahydroazepinyl, all optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 5 carbon atoms, --OH, --NO.sub.2, --CF.sub.3, halogen and acyl of an organic carboxylic acid of 1 to 7 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic activity, antidepression and anxiolytic properties.

    摘要翻译: 式Ⅰ的新型α-巯基甲基 - 苯丙酰胺,其中R 1选自氢和R 1'选自1至5个碳原子的烷基和任选被 由-OH,-NO 2,卤素和1至5个碳原子的烷基和烷氧基组成的组中的至少一个成员,X和X'分别选自氢,烷基和1至5个碳原子的烷氧基, -OH,卤素和-CF 3,R 2选自吡咯烷基,吗啉基,哌啶基,哌嗪基,四氢噻嗪基和六氢氮杂卟啉,全部任选被至少一个由1至5个碳原子的烷基和烷氧基组成的组取代 具有1至7个碳原子的有机羧酸的-OH,-NO 2,-CF 3,卤素和酰基及其具有止痛活性,抗抑郁和抗焦虑性质的无毒的药学上可接受的酸加成盐。

    Method of relieving pain with mercaptoalkanamides
    5.
    发明授权
    Method of relieving pain with mercaptoalkanamides 失效
    消除痛觉消炎痛的方法

    公开(公告)号:US5098934A

    公开(公告)日:1992-03-24

    申请号:US542731

    申请日:1990-06-22

    摘要: Novel .omega.-mercaptopropanamides and their homologs of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen and ##STR2## R.sub.1 ' is selected from the group consisting of alkyl of 1 to 5 carbon atoms and aryl optionally substituted with at least one member of the group consisting of --OH, alkyl and alkoxy of 1 to 5 carbon atoms, --NO.sub.2 and halogen, n is an integer from 1 to 5, R.sub.2 is selected from the group consisting of hydrogen alkyl of 1 to 5 carbon atoms and aryl and aralkyl of 6 to 15 carbon atoms optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 5 carbon atoms, --OH, halogen and --CF.sub.3, R.sub.3 is selected from the group consisting of a) hydrogen, b) phenyl optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 5 carbon atoms, --OH, --NO.sub.2, halogen, --CF.sub.3, carboxymethyl, alkoxycarbonylmethyl with 1 to 5 alkoxy carbon atoms, aralkoxy of 7 to 15 carbon atoms and ##STR3## and c) a heterocycle selected from the group consisting of thiazolyl, 4,5-dihydro-thiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl, tetrazolyl, benzimidazolyl, benzothiazolyl and benzoxazolyl, all optionally substituted with alkyl of 1 to 5 carbon atoms, X and X' are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms and their salts with non-taxic, pharmaceutically acceptable acids and bases with the proviso that when R.sub.2 is hydrogen and n is 1, R.sub.3 is not phenyl optionally substituted with at least one member of the group consisting of halogen and alkyl and alkoxy of 1 to 5 carbon atoms and when R.sub.2 is methyl and n is 1, R.sub.3 is not phenyl substituted with carboxymethyl having very good analgesic activity and enkephalinase inhibiting activity.

    摘要翻译: 新型ω-巯基丙酰胺及其同系物式(Ⅰ)其中R 1选自氢和R 1'选自1至5个碳原子的烷基和任选被 由1至5个碳原子的-OH,烷基和烷氧基组成的组中的至少一个,-NO 2和卤素,n是1至5的整数,R 2选自1至5个碳的烷基 6至15个碳原子的芳基和芳烷基,任选被至少一个由1至5个碳原子的烷基和烷氧基取代的基团,-OH,卤素和-CF 3,R 3选自 )氢,b)任选被至少一个由1-5个碳原子的烷基和烷氧基取代的苯基,-OH,-NO 2,卤素,-CF 3,羧甲基,具有1至5个烷氧基碳原子的烷氧羰基甲基, 7至15个碳原子的芳烷氧基和c)a 选自噻唑基,4,5-二氢 - 噻唑基,吡啶基,恶唑基,异恶唑基,咪唑基,嘧啶基,四唑基,苯并咪唑基,苯并噻唑基和苯并恶唑基的杂环,全部任选被1至5个碳原子的烷基取代,X和X “独立地选自氢和1至5个碳原子的烷基,并且它们与非税,药学上可接受的酸和碱的盐,条件是当R 2是氢且n是1时,R 3不是任选被取代的苯基 与卤素和1至5个碳原子的烷基和烷氧基中的至少一个成员,当R 2是甲基且n是1时,R 3不是具有非常好的镇痛活性和脑啡肽酶抑制活性的羧甲基取代的苯基。

    8-amino decahydroquinolines and medicinal use thereof
    6.
    发明授权
    8-amino decahydroquinolines and medicinal use thereof 失效
    8-氨基十氢喹啉及其医药用途

    公开(公告)号:US4963567A

    公开(公告)日:1990-10-16

    申请号:US371995

    申请日:1989-06-27

    CPC分类号: C07D215/40

    摘要: A compound selected from the group consisting of all enantiomeric and diastereoisomeric forms of a decahydroquinoline of the formula ##STR1## wherein R.sub.1 is alkyl of 1 to 5 carbon atoms, R.sub.2 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, A is selected from the group consisting of --(CH.sub.2).sub.n --, --CH.sub.2 O-- and alkylene substituted with alkyl having a total of 2 to 8 carbon atoms, n is an integer from 0 to 5, Z is selected from the group consisting of optionally substituted phenyl, optionally substituted naphthyl, optionally substituted indenyl, optionally substituted heteromonocycle of 5 to 6 members and optionally substituted hetero-bicycle with the proviso that when Z is o-alkoxy-phenyl, A is not --(CH.sub.2).sub.n -- in which n is O, and their non-toxic, pharmaceutically acceptable acid addition salts and their quaternary ammonium salts and intermediates having analgesic, diuretic, hypotensive, anti-arrithmic and anti-cerebral-ischaemic properties.

    Method of inducing immunostimulating activity
    7.
    发明授权
    Method of inducing immunostimulating activity 失效
    诱导免疫刺激活性的方法

    公开(公告)号:US4880803A

    公开(公告)日:1989-11-14

    申请号:US103919

    申请日:1987-10-01

    CPC分类号: A61K31/40

    摘要: A method of inducing immunostimulating activity in warm-blooded animals comprising administering to warm-blooded animals an immunostimulating amount of at least one maleo-pimaric acid compound of the formula ##STR1## wherein R.sub.1 and R.sub.2 together with the nitrogen to which they are attached form an optionally substituted saturated heterocycle optionally containing at least one other heteroatom, Y is selected from the group consisting of hydrogen, amino, alkyl of 1 to 5 carbon atoms optionally substituted with at least one hydroxy, dialkylamino with alkyl of 1 to 5 carbon atoms, alkoxy carbonyl of 2 to 5 carbon atoms, acyl of an organic carboxylic acid of 1 to 5 carbon atoms and ##STR2## X is an alkylene of 1 to 5 carbon atoms and R.sub.1 and R.sub.2 have the above definition.

    摘要翻译: 一种在温血动物中诱导免疫刺激活性的方法,包括向温血动物施用免疫刺激量的至少一种下式的马来酸 - 海松酸化合物,其中R1和R2与它们所连接的氮一起 形成任选地含有至少一个其它杂原子的任选取代的饱和杂环,Y选自氢,氨基,任选被至少一个羟基,二烷基氨基与1至5个碳原子的烷基取代的1至5个碳原子的烷基 2至5个碳原子的烷氧基羰基,1至5个碳原子的有机羧酸的酰基,X是1至5个碳原子的亚烷基,R 1和R 2具有上述定义。

    Novel anti-inflammatory treatment
    8.
    发明授权
    Novel anti-inflammatory treatment 失效
    新型抗炎治疗

    公开(公告)号:US4614736A

    公开(公告)日:1986-09-30

    申请号:US718175

    申请日:1985-04-01

    CPC分类号: A61K31/57

    摘要: A novel method of treating inflammation of the colon and rectum of warm-blooded animals comprising administering to the colon and rectum of warm-blooded animals an anti-inflammatorily effective amount of 9.alpha.,11.beta.-dichloro-16.alpha.-methyl-21-oxycarbonyldicyclohexylmethoxy-.DELTA..sup.1,4 -pregnadiene-3,20-dione.

    摘要翻译: 一种治疗温血动物结肠和直肠炎症的新方法,包括向结肠和直肠的温血动物施用抗炎剂有效量的9α,11β-二氯-16α-甲基-21- 氧羰基二环己基甲氧基-TATA1,4-孕烯二烯-3,20-二酮。

    Novel indanes
    9.
    发明授权
    Novel indanes 失效
    新的indanes

    公开(公告)号:US5234944A

    公开(公告)日:1993-08-10

    申请号:US970776

    申请日:1992-11-03

    IPC分类号: C07D295/135 C07D311/96

    CPC分类号: C07D295/135 C07D311/96

    摘要: A compound selected from the group consisting of enantiomers and diastereoisomer forms and mixtures thereof of the formula ##STR1## wherein R.sub.6 is selected from the group consisting of hydrogen, halogen and alkyl and alkoxy of 1 to 5 carbon atoms, R.sub.1 and R.sub.2 are individually hydrogen or alkyl of 1 to 5 carbon atoms or taken together with the carbon atoms to which they are attached form a cycloalkyl of 3 to 6 carbon atoms optionally containing a heteroatom selected from the group consisting of --S--, --O-- and --N--, one of A and B has the formula ##STR2## and the other has the formula ##STR3## R is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, Z is selected from the group consisting of --(CH.sub.2).sub.n --, branched alkylene of 2 to 8 carbon atoms and --CH.sub.2 O--, n is an integer of 0 to 5, X, X' and X" are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 4 carbon atoms, halogen, --OH, --CF.sub.3, --NO.sub.2, --NH.sub.2, mono and dialkylamino of 1 to 4 alkyl carbon atoms and sulfamino, R.sub.3 and R.sub.4 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms or taken together with the nitrogen atom to which they are attached form a 5 to 6 member heterocycle optionally containing a member of the group consisting of --O--, --S-- and ##STR4## R.sub.1 ' is hydrogen or alkyl of 1 to 4 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a strong affinity for optical receptors, central analgesic, diuretic, anti-arrythmic, hypotensive and cerebral anti-ischemic activity.

    摘要翻译: 选自下组的对映异构体和非对映异构体形式的化合物及其混合物,其中R 6选自氢,卤素和1至5个碳原子的烷基和烷氧基,R 1和R 2分别为 氢或1至5个碳原子的烷基或与它们所连接的碳原子一起形成3至6个碳原子的环烷基,任选地含有选自-S - , - O-和-N - ,A和B中的一个具有式,另一个具有式(Ia)的化合物,其选自氢和1至5个碳原子的烷基,Z选自 - ( CH 2)n支链亚烷基,-CH 2 O-,n为0〜5的整数,X,X'和X“分别选自氢,烷基和烷氧基的1 至4个碳原子,卤素,-OH,-CF 3,-NO 2,-NH 2,1至4个烷基的单和二烷基氨基 碳原子和磺氨基,R3和R4分别选自氢和1至5个碳原子的烷基,或与它们所连接的氮原子一起形成5至6个成员杂环,任选地含有 由-O-,-S-和R IMA'组成的基团是氢或1至4个碳原子的烷基,它们对光学受体具有强亲和力的无毒的药学上可接受的酸加成盐,中枢性镇痛药,利尿剂, 抗焦虑,降压和脑抗缺血活性。

    Novel 4-hydroxy-3-pyridine-carboxamides useful for treating inflammation
and rheumatism
    10.
    发明授权
    Novel 4-hydroxy-3-pyridine-carboxamides useful for treating inflammation and rheumatism 失效
    用于治疗炎症和风湿病的新型4-羟基-3-吡啶 - 甲酰胺

    公开(公告)号:US4925859A

    公开(公告)日:1990-05-15

    申请号:US167375

    申请日:1988-03-31

    CPC分类号: C07D213/82 C07D417/12

    摘要: Novel pyridines of the formula ##STR1## wherein R is selected from the group consisting of (a) phenyl optionally substituted with at least one member of the group consisting of hydroxy, alkyl and alkoxy of 1 to 5 carbon atoms, halogen, --CF.sub.3 and --NO.sub.2 and (b) a 5 to 6 member hetercyclic optionally substituted with alkyl of 1 to 5 carbon atoms, R.sub.1 and R.sub.2 are individually selected from the group consisting of (a) alkyl of 1 to 5 carbon atoms, (b) 5 to 6 member heterocyclic optionally substituted with alkyl of 1 to 5 carbon atoms and (c) phenyl and naphthyl optionally substituted with at least one member of the group consisting of hydroxy, alkyl and alkoxy of 1 to 5 carbon atoms, halogen, --NO.sub.3 and --CF.sub.3, R.sub.3 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, --(CF.sub.2).sub.n --CF.sub.3 and ##STR2## n is an integer from 0 to 4 and Alk is alkyl of 1 to 5 carbon atoms and their non-toxic, pharmaceutically acceptable salts with acids and bases having anti-inflammatory and anti-rheumatic properties.

    摘要翻译: 式(I)的新吡啶,其中R选自(a)任选被至少一个由1-5个碳原子的羟基,烷基和烷氧基组成的组中的一个取代基取代的苯基,卤素,-CF 3 和(b)任选被1至5个碳原子的烷基取代的5至6元杂环,R 1和R 2分别选自(a)1至5个碳原子的烷基,(b)5 至(C)任选被1至5个碳原子的烷基取代的6元杂环,和(c)任选被至少一个选自1至5个碳原子的烷基和烷氧基的基团取代的苯基和萘基,卤素,-NO 3和 -CF 3,R 3选自氢,1〜5个碳原子的烷基, - (CF 2)n -CF 3,n为0〜4的整数,Alk为1〜5个碳原子的烷基 和它们的无毒,药学上可接受的盐与酸和碱具有抗炎和抗风湿性 matic属性。